ADVANCED LEIOMYOSARCOMA
Clinical trials for ADVANCED LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tumor 'Mini-Me' could personalize sarcoma therapy
Disease control ENROLLING_BY_INVITATIONThis study tests whether growing a patient's tumor cells in the lab (called organoids) can help doctors choose the most effective first chemotherapy for advanced leiomyosarcoma. About 50 adults with newly diagnosed advanced disease will have their tumor biopsied and tested agains…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Promising drug combo targets rare sarcoma in early trial
Disease control OngoingThis study tests a new combination of two drugs, lurbinectedin and doxorubicin, for people with advanced leiomyosarcoma, a rare soft tissue cancer. The first part finds a safe dose, and the second part compares the combination to lurbinectedin alone to see which works better. Abo…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 13, 2026 16:03 UTC